Bayer’s Yasmin Lawsuit Settlements Rise to $402.6 Million

Bayer AG said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots in women have increased to more than $402 million.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.